Additionally, research has identified several genetic and epigenetic alterations that contribute to the development and progression of prostate cancer, including alterations in the tumor suppressor genes PTEN and p53 [6], and the oncogene MYC [7]. The gene discussed is TP53; the disease is prostate carcinoma.